Growth Metrics

Thermo Fisher Scientific (TMO) Short-Term Debt issuances (2016 - 2023)

Thermo Fisher Scientific's Short-Term Debt issuances history spans 15 years, with the latest figure at $593.0 million for Q3 2023.

  • For the quarter ending Q3 2023, Short-Term Debt issuances rose 46.06% year-over-year to $593.0 million, compared with a TTM value of $593.0 million through Mar 2024, down 69.23%, and an annual FY2025 reading of $1.1 billion, changed N/A over the prior year.
  • Short-Term Debt issuances for Q3 2023 was $593.0 million at Thermo Fisher Scientific, down from $1.0 billion in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $2.5 billion in Q4 2021, with the low at $1.0 million in Q2 2020.
  • Average Short-Term Debt issuances over 5 years is $678.6 million, with a median of $406.0 million recorded in 2022.
  • Biggest YoY gain for Short-Term Debt issuances was 282.0% in 2020; the steepest drop was 99.94% in 2020.
  • Tracing TMO's Short-Term Debt issuances over 5 years: stood at $200.0 million in 2019, then crashed by 99.5% to $1.0 million in 2020, then skyrocketed by 251100.0% to $2.5 billion in 2021, then crashed by 88.26% to $295.0 million in 2022, then skyrocketed by 101.02% to $593.0 million in 2023.
  • Per Business Quant, the three most recent readings for TMO's Short-Term Debt issuances are $593.0 million (Q3 2023), $1.0 billion (Q2 2023), and $295.0 million (Q4 2022).